MSCoreSys is a research consortium that aims to establish mass spectrometric technologies in systems medicine to aid therapeutic decision-making in various diseases. Systems medicine increasingly contributes to understanding complex physiological and pathological processes, early diagnosis, and developing more precise therapies. Since mass spectrometry is emerging as a key technology for the characterization of proteins and metabolites as diagnostic biomolecules...
Prof. Dr. Ulrich Keilholz
Director of the Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin
Prof. Dr. Frederick Klauschen
Director of the Institute for Pathology, Ludwig-Maximilians-University Munich Group leader at the …
Prof. Dr. Ursula Klingmüller
DKFZ - Systems Biology of Signal Transduction (B200)
Prof. Dr. Jeroen Krijgsveld
DKFZ & University Hospital Heidelberg - Proteomics of Stem Cells and Cancer (B230)
Prof. Dr. Bernhard Küster
Technische Universität München - Proteomics and Bioanalytics
Prof. Dr. Carsten Müller-Tidow
University Hospital Heidelberg - Clinic for Haematology, Oncology and Rheumatology
Prof. Dr. Markus Ralser
Director of the Institute for Biochemistry, Charité – Universitätsmedizin Berlin
Prof. Dr. Matthias Selbach
Group leader „Proteome Dynamics“, Max-Delbrück-Center for Molecular Medicine, Berlin
Prof. Dr. Stefan Tenzer
Universitätsmedizin Mainz - Institut für Immunologie / Quantitative Proteomics
Prof. Dr. Daniel Teupser
LMU Klinikum - Institut für Laboratoriumsmedizin
Prof. Dr. Philipp Wild
Universitätsmedizin Mainz - Klinische Epidemiologie
MSCoreSys / DIASyM
UNIVERSITY MEDICAL CENTER
of the Johannes Gutenberg-University Mainz
PAUL-KLEIN-CENTER FOR IMMUNINTERVENTION
Building 308A
Langenbeckstrasse 1
D-55131 Mainz
Germany